Effects of supplementing LCPUFA to the diet of pregnant women

Data from RCT

Research output: Chapter in Book/Report/Conference proceedingConference contribution

7 Citations (Scopus)

Abstract

Randomised controlled trials (RCTs) investigating the effect of n-3 long-chain polyunsaturated fatty acid (LCPUFA) supplementation on pregnancy outcomes were recently systematically reviewed for both low-risk (uncomplicated) and high-risk pregnancies. The duration of pregnancy was found to be significantly enhanced by n-3 LCPUFA supplementation in low-risk (two systematic reviews, weighted mean difference: 2.55 and 1.57 days, 95% CI: 1.13-4.07 and 0.35-2.78 days), but not in high-risk pregnancies. The relative risk of giving birth before the 34th week of gestation was found to be reduced by n-3 LCPUFA supplementation both in low-risk (0. 69, 95% CI: 0.49-0.99) and in high-risk (0. 39, 95% CI: 0.19-0.84) pregnancies. Recent evidence indicates that enhancement of maternal intake of n-3 LCPUFA prolongs the duration of gestation in low-risk pregnancies and may contribute to the prevention of early preterm birth in both low-risk and high-risk pregnancies.

Original languageEnglish
Title of host publicationAdvances in Experimental Medicine and Biology
Pages65-69
Number of pages5
Volume646
DOIs
Publication statusPublished - 2009

Publication series

NameAdvances in Experimental Medicine and Biology
Volume646
ISSN (Print)00652598

Fingerprint

Nutrition
Unsaturated Fatty Acids
Pregnant Women
Randomized Controlled Trials
Diet
High-Risk Pregnancy
Pregnancy
Premature Birth
Pregnancy Outcome
Mothers
Parturition

Keywords

  • Docosahexaenoic acid
  • Long-chain polyunsaturated fatty acid
  • Pregnancy

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Decsi, T. (2009). Effects of supplementing LCPUFA to the diet of pregnant women: Data from RCT. In Advances in Experimental Medicine and Biology (Vol. 646, pp. 65-69). (Advances in Experimental Medicine and Biology; Vol. 646). https://doi.org/10.1007/978-1-4020-9173-5_7

Effects of supplementing LCPUFA to the diet of pregnant women : Data from RCT. / Decsi, T.

Advances in Experimental Medicine and Biology. Vol. 646 2009. p. 65-69 (Advances in Experimental Medicine and Biology; Vol. 646).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Decsi, T 2009, Effects of supplementing LCPUFA to the diet of pregnant women: Data from RCT. in Advances in Experimental Medicine and Biology. vol. 646, Advances in Experimental Medicine and Biology, vol. 646, pp. 65-69. https://doi.org/10.1007/978-1-4020-9173-5_7
Decsi T. Effects of supplementing LCPUFA to the diet of pregnant women: Data from RCT. In Advances in Experimental Medicine and Biology. Vol. 646. 2009. p. 65-69. (Advances in Experimental Medicine and Biology). https://doi.org/10.1007/978-1-4020-9173-5_7
Decsi, T. / Effects of supplementing LCPUFA to the diet of pregnant women : Data from RCT. Advances in Experimental Medicine and Biology. Vol. 646 2009. pp. 65-69 (Advances in Experimental Medicine and Biology).
@inproceedings{a5a608e132f94dea94c2034f53ed0ee4,
title = "Effects of supplementing LCPUFA to the diet of pregnant women: Data from RCT",
abstract = "Randomised controlled trials (RCTs) investigating the effect of n-3 long-chain polyunsaturated fatty acid (LCPUFA) supplementation on pregnancy outcomes were recently systematically reviewed for both low-risk (uncomplicated) and high-risk pregnancies. The duration of pregnancy was found to be significantly enhanced by n-3 LCPUFA supplementation in low-risk (two systematic reviews, weighted mean difference: 2.55 and 1.57 days, 95{\%} CI: 1.13-4.07 and 0.35-2.78 days), but not in high-risk pregnancies. The relative risk of giving birth before the 34th week of gestation was found to be reduced by n-3 LCPUFA supplementation both in low-risk (0. 69, 95{\%} CI: 0.49-0.99) and in high-risk (0. 39, 95{\%} CI: 0.19-0.84) pregnancies. Recent evidence indicates that enhancement of maternal intake of n-3 LCPUFA prolongs the duration of gestation in low-risk pregnancies and may contribute to the prevention of early preterm birth in both low-risk and high-risk pregnancies.",
keywords = "Docosahexaenoic acid, Long-chain polyunsaturated fatty acid, Pregnancy",
author = "T. Decsi",
year = "2009",
doi = "10.1007/978-1-4020-9173-5_7",
language = "English",
isbn = "9781402091728",
volume = "646",
series = "Advances in Experimental Medicine and Biology",
pages = "65--69",
booktitle = "Advances in Experimental Medicine and Biology",

}

TY - GEN

T1 - Effects of supplementing LCPUFA to the diet of pregnant women

T2 - Data from RCT

AU - Decsi, T.

PY - 2009

Y1 - 2009

N2 - Randomised controlled trials (RCTs) investigating the effect of n-3 long-chain polyunsaturated fatty acid (LCPUFA) supplementation on pregnancy outcomes were recently systematically reviewed for both low-risk (uncomplicated) and high-risk pregnancies. The duration of pregnancy was found to be significantly enhanced by n-3 LCPUFA supplementation in low-risk (two systematic reviews, weighted mean difference: 2.55 and 1.57 days, 95% CI: 1.13-4.07 and 0.35-2.78 days), but not in high-risk pregnancies. The relative risk of giving birth before the 34th week of gestation was found to be reduced by n-3 LCPUFA supplementation both in low-risk (0. 69, 95% CI: 0.49-0.99) and in high-risk (0. 39, 95% CI: 0.19-0.84) pregnancies. Recent evidence indicates that enhancement of maternal intake of n-3 LCPUFA prolongs the duration of gestation in low-risk pregnancies and may contribute to the prevention of early preterm birth in both low-risk and high-risk pregnancies.

AB - Randomised controlled trials (RCTs) investigating the effect of n-3 long-chain polyunsaturated fatty acid (LCPUFA) supplementation on pregnancy outcomes were recently systematically reviewed for both low-risk (uncomplicated) and high-risk pregnancies. The duration of pregnancy was found to be significantly enhanced by n-3 LCPUFA supplementation in low-risk (two systematic reviews, weighted mean difference: 2.55 and 1.57 days, 95% CI: 1.13-4.07 and 0.35-2.78 days), but not in high-risk pregnancies. The relative risk of giving birth before the 34th week of gestation was found to be reduced by n-3 LCPUFA supplementation both in low-risk (0. 69, 95% CI: 0.49-0.99) and in high-risk (0. 39, 95% CI: 0.19-0.84) pregnancies. Recent evidence indicates that enhancement of maternal intake of n-3 LCPUFA prolongs the duration of gestation in low-risk pregnancies and may contribute to the prevention of early preterm birth in both low-risk and high-risk pregnancies.

KW - Docosahexaenoic acid

KW - Long-chain polyunsaturated fatty acid

KW - Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=70349234264&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349234264&partnerID=8YFLogxK

U2 - 10.1007/978-1-4020-9173-5_7

DO - 10.1007/978-1-4020-9173-5_7

M3 - Conference contribution

SN - 9781402091728

VL - 646

T3 - Advances in Experimental Medicine and Biology

SP - 65

EP - 69

BT - Advances in Experimental Medicine and Biology

ER -